STAT+: Online care is caught in the crossfire as states crack down on corporate medicine
Growing legislative scrutiny across multiple states targets the corporate structure underlying most direct-to-consumer telehealth businesses.
Tag
Health Tech
Live stream
RIVO news Listen to this section's headlines in an AI voice
Now:
Press play to start the stream
This browser does not support voice playback. Try Chrome, Edge or Safari.
Opinion: The virtual end of the doctor’s office waiting room
It’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.
Health tech
STAT+: Executives reveal tech initiatives at Summa Health, eight months after General Catalyst acquisition
Two years after General Catalyst said it was buying Ohio safety-net hospital Summa Health, executives shed light on how the “transformation” is going.
Health tech
STAT+: Oura brings rings to the cuffless blood pressure party
In this edition of STAT Health Tech: A new wave of blood pressure monitoring wearables, Stanford asking patients about AI, and more.
Health tech
STAT+: Blood pressure tech floods the market after FDA relaxes wearables oversight
Wearables with unvalidated blood pressure measuring tech are flooding the market after the FDA relaxed oversight of wellness devices.
AI Prognosis
STAT+: Where patients and hospitals disagree about AI
In this edition of AI Prognosis, Brittany Trang takes a look at patients' role in how Stanford Health Care adopts AI tools, and more health AI news.
Health tech
STAT+: How Stanford patients help expose ‘fault lines’ in health AI adoption
Stanford Health Care started asking patients about new AI tools before they are implemented. Here's what patients are telling them.
Biotech
What do early data from Utah’s Doctronic AI pilot show?
In this edition of STAT Health Tech: Early data from a Utah pilot using AI to renew prescriptions, Oura files to go public, and more.
Biotech
STAT+: An AI biotech CEO sets the record straight on AI drug development hype
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug development.
Apple
The Apple Watch is 11 years old and losing momentum. Screenless rivals are winning the next phase.
The Apple Watch generated an estimated $100 billion in lifetime sales and transformed the smartwatch market. Eleven years after launch, innovation has slowed and the lineup is losing momentum. Bloomberg’s…